Prostate Cancer - Results from #26680

Integration of regulatory networks by NKX3.1 promotes androgen-dependent prostate cancer survival - Abstract December 12, 2011

Comparison of template-matching and singular-spectrum-analysis methods for imaging implanted brachytherapy seeds - Abstract December 12, 2011

Novel vitamin D analogs for prostate cancer therapy - Abstract December 12, 2011

Biochemical control with radiotherapy improves overall survival in intermediate and high-risk prostate cancer patients who have an estimated 10-year overall survival of >90% - Abstract December 9, 2011

Variation in use of androgen suppression with external-beam radiotherapy for nonmetastatic prostate cancer - Abstract December 9, 2011

The gap junction protein Cx43 is involved in the bone-targeted metastatic behaviour of human prostate cancer cells - Abstract December 9, 2011

Risk prediction for prostate cancer recurrence through regularized estimation with simultaneous adjustment for nonlinear clinical effects - Abstract December 9, 2011

Does pharmacological castration as adjuvant therapy for prostate cancer after radiotherapy affect anxiety and depression levels, cognitive functions and quality of life - Abstract December 9, 2011

New ultrasound technologies for the diagnostics of prostate cancer - Abstract December 9, 2011

Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells - Abstract December 9, 2011

Predictive value in the analysis of RNASEL genotypes in relation to prostate cancer - Abstract December 9, 2011

Cause-specific mortality following radical prostatectomy - Abstract December 9, 2011

Cost-effectiveness of Prostate Health Index for prostate cancer detection - Abstract December 8, 2011

Role and expression of FRS2 and FRS3 in prostate cancer - Abstract December 8, 2011

Association of prostate cancer risk alleles with unfavourable pathological characteristics in potential candidates for active surveillance - Abstract December 8, 2011

Surgical therapy for intermediate risk prostate cancer - Abstract December 8, 2011

Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: The essential importance of percentage of positive cores - Abstract December 8, 2011

ERG immunohistochemistry is not predictive for PSA recurrence, local recurrence or overall survival after radical prostatectomy for prostate cancer - Abstract December 8, 2011

Quality of life after hypofractionated concomitant intensity-modulated radiotherapy boost for high-risk prostate cancer - Abstract December 8, 2011

Beta-carotene antioxidant use during radiation therapy and prostate cancer outcome in the physicians' health study - Abstract December 8, 2011

Page 1335 of 1437